Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

GSK plc

GLAXFPNK
Healthcare
Drug Manufacturers - General
$29.40
$-1.80(-5.77%)
U.S. Market opens in 8h 25m

GSK plc (GLAXF) Stock Overview

Explore GSK plc’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap118.6B
P/E Ratio15.32
EPS (TTM)$1.89
ROE0.37%
Fundamental Analysis

AI Price Forecasts

1 Month$33.15
3 Months$35.01
1 Year Target$22.26

GLAXF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of GSK plc (GLAXF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 57.59, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $22.26.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 15.32 and a market capitalization of 118.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-5.77%
5-Day Change
-6.61%
1-Month Change
26.23%
3-Month Change
22.55%
6-Month Change
47.74%
Year-to-Date (YTD) Change
24.58%
1-Year Change
61.36%
3-Year Change
69.06%
5-Year Change
39.93%
All-Time (Max) Change
16.44%

Contact Information

44 20 8047 5000
980 Great West Road, Brentford, TW8 9GS

Company Facts

68,629 Employees
IPO DateJan 5, 2010
CountryGB
Actively Trading

Frequently Asked Questions